Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs... see more

TSX:TH - Post Discussion

Theratechnologies Inc > TaiMed Biologics up 20% in 2 days
View:
Post by longterm56 on Aug 30, 2022 10:33pm

TaiMed Biologics up 20% in 2 days

Anyone know what's causing TaiMed to be up 10% (max allowed on Taiwan exchange) in each of the last two days?

   -LT
Comment by SPCEO1 on Aug 31, 2022 12:11am
I looked at it briefly after the first 10% jump but did not find any obvious reason. But I need to look more closely.
Comment by qwerty22 on Aug 31, 2022 9:13am
Looks like they've had these moments before over the course of the past year. It hasn't stopped the slow decline of the stock.
Comment by SPCEO1 on Aug 31, 2022 11:07am
I was not able to find any news item or other reason for the jump in Taimed's share price. Perhaps they are about to sell more stock and the underwriter is pumping the stock price up for that? They have about $25million in cash left, $25 million in debt and had negative cash flow of around $18 million over the last year.
Comment by qwerty22 on Aug 31, 2022 4:48pm
Their monthly revenue is consistently down +50% YoY in 2022. Maybe investors/analysts have some hope in their follow on products. At least those products are more inline with what other HIV companies are seeking to develop. https://ir.taimedbiologics.com/irwebsite/monthlysales.php
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities